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Background: Type 1 diabetes in young children is a heavy parental burden. As part of
pilot phase of the KIDSAP01 study, we conducted a baseline assessment in parents to
study the association between hypoglycemia fear, parental well-being and child behavior.
Methods: All parents were invited to fill in baseline questionnaires: hypoglycemia fear
survey (HFS), WHO-5, Epworth Sleepiness Scale and Strength and Difficulties
Questionnaire (SDQ).
Results: 24 children (median age: 5-year, range 1-7 years, 63% male, mean diabetes
duration: 3 ± 1.7 years) participated. 23/24 parents filled out the questionnaires. We found
a higher score for the hypoglycemia fear behavior 33.9 ± 5.6 compared to hypoglycemia
worry 34.6 ± 12.2. Median WHO-5 score was 16 (8 - 22) with poor well-being in two
parents. Median daytime sleepiness score was high in five parents (>10). For six children a
high total behavioral difficulty score (>16) was reported. Pro social behavior score was
lower than normal in six children (<6). Parental well-being was negatively associated with
HFS total (r = - 0.50, p <.05) and subscale scores (r = - 0.44, p <.05 for HFS-Worry and
HFS-Behavior), child behavior (r = - 0.45, p = .05) and positively with child age andn.org August 2021 | Volume 12 | Article 7210281
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Frontiers in Endocrinology | www.frontiersidiabetes duration (r = 0.58, p <.01, r = 0.6, p <.01). HFS, parental well-being nor daytime
sleepiness are associated with the HbA1c.
Conclusion: Regular screening of parental well-being, hypoglycemia fear and child
behavior should be part of routine care to target early intervention.Keywords: hypoglycemia fear, parental well-being, very young children, type 1 diabetes, child behavior, sleepinessINTRODUCTION
International recommendations propose a HbA1c of <7.0% (<53
mmol/mol) in persons with type 1 diabetes (T1D) to prevent
acute and late complications (1). Achieving near normal glucose
values requires a continuous adjustment of insulin treatment
around food intake, daily activities and hormonal changes. In
preschool children these choices are determined by the parent/
caregiver and pose continuous challenges and stress (2).
Especially the fear of hypoglycemia has been associated with
increased stress in parents of younger children (3–5). Fear of
hypoglycemia can lead to frequent nocturnal blood glucose
measurements and subsequent sleep deprivation (6), which in
turn may affect parents´ well-being as well as the (perceived)
behavior of their child (7, 8). New technology such as insulin or
sensor-augmented pumps should improve metabolic control.
Better control may reduce (perceived) child behavioral
problems (9) and parental anxiety around high and low blood
glucose excursions (7, 10). Regardless of treatment regimen,
parents/caregivers of young children with T1D often report
their anxiety caused by glucose fluctuations during the night
(11, 12). This suggests that these technologies, although
providing improved metabolic outcome, may not yet alleviate
parental stress levels.
Next steps in technology advancement include the use of the
artificial pancreas, where different algorithms are used to steer
insulin administration (13). An initial evaluation of the use of the
Cambridge algorithm in toddlers demonstrated the feasibility of
hybrid closed-loop insulin delivery in young children with
diabetes (14), whereby parents reported reduced diabetes
management burden and improved sleep quality (15). The
current paper presents data from this baseline assessment with
a specific focus on parental well-being in relation to fear
of hypoglycemia.METHODS
The KIDSAP01 study (NCT03101865) aims to evaluate a hybrid
closed-loop insulin administration system, based on the
Cambridge algorithm, under free-living conditions in very
young children with T1D. A feasibility study was conducted to
pretest the setup of the large-scale trial and to determine the
specific needs of young children with T1D and their parents. In
regards to the latter, parents of children participating in study
completed questionnaires on hypoglycemia fear, parental well-
being, daytime sleepiness and child behavior at baseline.n.org 2Participants
The patient population has been described in detail previously
(14, 15). To summarize, 24 children (median age 5 years, range
1-7 years, 63% male) with T1D from four countries (UK,
Luxembourg, Germany and Austria) and seven clinics were
included. Mean diabetes duration was 3.0 ± 1.7 years (range
0.5-6.4 years). All children were treated for at least three months
with insulin pumps. The majority of children (n=18) used the
Medtronic 640G pumps, 4 had a Medtronic 554 pump, 1 used an
Animas Vibe and 1 a Roche Insight. The Medtronic Guardian
REAL time sensor was used by 15 children, the ABBOTT LIBRE
was used by 4 children and 3 children did not wear a sensor at
baseline of this study.
HbA1c levels at baseline were used as an indicator of
metabolic control (mean HbA1c, 7.4 ± 0.7% (57 ± 8 mmol/
mol) and range 5.9-8.7% (41 - 72 mmol/mol). In the three
months prior to the study, no severe hypoglycemia nor diabetic
ketoacidosis had been observed. Twenty-three of the 24 parents
filled out the questionnaire at the start of the study.
Measures
The Hypoglycemia Fear Survey (HFS) for Parents (16) is a 26-
item survey comprised of a HFS-worry and a HFS-behavior
subscale. All items are scored on a 5-point Likert scale (1 =
“never” ; 5 = “always”). Higher scores reflect higher
hypoglycemia fear.
The WHO-5 questionnaire has been extensively used to
assess well-being in persons with diabetes and their family
(17). It includes five items, with item scores ranging from 0 to
5. Scores under 13 are indicative of poor well-being and a score of
below 7 warrants further testing for depression (18).
The Epworth Sleepiness scale evaluates sleepiness and risk to
doze off during the day (19). It includes eight questions, scored
between 0 and 3, whereby total scores > 9 indicate
excessive sleepiness.
The strength and difficulties questionnaire is a screening tool
to identify psychosocial problems in (pre-)school children (20–
22). It includes 25 items comprising four subscales measuring
difficulties (emotional, conduct or peer problems and
hyperactivity), and a pro-social subscale rating the strengths.
The total score is based on the first 4 subscales, whereby a total
score > 15 is indicative of a high risk for psychosocial
problems (23).
Statistical Analyses
First descriptive data will be reviewed to identify the percentage
of parents scoring within (ab)normal ranges on the standardizedAugust 2021 | Volume 12 | Article 721028
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identify relationships between indicators of parental well-being
and child metabolic control and behavior. Based on previous
research we expected positive relationships between parental
well-being and metabolic control and child behavior. Given the
exploratory nature of the pilot study, no a-priori power analyses
were conducted.RESULTS
Descriptive results are provided in Table 1. Results suggest that
parents´ fear of hypoglycemia is signified by their behavior
rather than their worries. Most pronounced fear-related
behaviors reflected parents making sure their child had access
to fast-acting carbohydrates and getting up in the middle of the
night to check the child´s blood sugar levels. High mean worry
scores were reported for low glucose levels whilst child was
sleeping and for parent not being around when the child has low
blood sugar. Poor well-being was reported by 2/23 (9%) parents,
whereas 5/23 (22%) parents scored low on the question ‘I woke
up feeling fresh and rested’. This question also generated the
lowest mean score for the sample as a whole (M=2.86, SD=1.46).
Excessive daytime sleepiness (scores >10) was reported by 5/23
(22%) parents. Although parent reported child behavioral
difficulties were on average within the normal range, scores for
three children were in the high range (scores 17-19) and for
another three in the very high range (i.e., scores ≥ 20). These
scores reflect elevated scores on especially the subscales conduct
and emotion. Pro-social behavior was very low for two children.
Parental well-being scores were negatively associated with
fear of hypoglycemia and child behavior but positively associated
with child age and diabetes duration (see Table 2). Parental
well-being scores were negatively associated with fear of
hypoglycemia total (r = - 0.50, p <.05) and subscale scoresFrontiers in Endocrinology | www.frontiersin.org 3(r = - 0.44, p <.05 for HFS-Worry and HFS-Behavior) and
child behavior (r = - 0.45, p = .05) but positively associated
with child age and diabetes duration (r = 0.58, p <.01, r = 0.60,
p <.01). All other between-measures correlations were not
significant (see Table 2).DISCUSSION
Parents of very young children with T1D reported on their
worries and behavior in relation to hypoglycemia before
commencing a closed-loop intervention. The hypoglycemic
fear ratings in the current sample were higher than previously
reported for a sample of parents of children with T1D aged 6 and
above (5). HFS-worry subscale scores were however comparable
to those reported by parents of children younger than 7 years
(12). Parents indicated they especially worry about hypoglycemia
during the night and will regularly get up to check the blood
glucose values in order to prevent hypoglycemia or reduce fear of
hypoglycemia. This confirms previous reports, suggesting that
nights are particularly difficult for parents of young children with
T1D (12).
No relationship was found between daytime sleepiness and
other constructs nor with child age or HbA1c. This lack of
association suggests that excessive daytime sleepiness in this
group of parents is not directly related to the management of
their child´s diabetes but could rather be caused by the poorer
quality of sleep of the child, general sleep deprivation or irregular
sleep patterns (24).
Poor well-being was observed in 2/23 (9%) parents. This
percentage is lower than previously reported in parents of youth
with diabetes, and may indicate that diabetes and its
management affects parental well-being differently depending
on the developmental stage of the child (25). The negative
association between nocturnal fear of hypoglycemia andTABLE 1 | Descriptive statistics (Mean, Standard Deviation, Median, Range) for scales used in the study.
Mean (SD) Median Range
Baseline
Strengths and Difficulties Questionnairea
Emotional Problems Subscale Score 2.35 (2.12) 2.00 0 - 7
Conduct Problems Subscale Score 3.26 (2.49) 3.00 0 -10
Hyperactivity Subscale Score 4.48 (2.15) 4.00 0 – 8
Peer Problems Subscale Score 1.35 (1.56) 1.00 0 – 5
Prosocial Subscale Score 7.13 (2.22) 8.00 1 – 10
Total Difficulties Score 11.44 (6.65) 11.00 2 – 25
Hypoglycemia Fear Survey Total Scoreb 68.52 (16.16) 70.00 44 - 105
Behavior Subscale Total Score 33.91 (5.58) 35.00 22 – 44
Worry Subscale Total Score 34.61 (12.18) 32.00 20 – 62
WHO-5 Total Scorec 16.78 (4.08) 16.00 8 - 22
Epworth Sleepiness Scale Total Scored 6.83 (5.38) 6.00 0 - 24August 2021 | Volume 12 | ArticlaSubscales are on scale 0-10. Total difficulties score is on scale 0-40. For total scale and all subscales except the prosocial subscale, a higher score denotes more difficulties and fewer
strengths. For the prosocial subscale, a higher score denotes more strengths and fewer difficulties.
bTotal score is on scale 26-130. Behavior subscale is on scale 11-55, and worry subscale is on scale 15-75. Higher score denotes more fear. Mean score for items on the HFS-B subscale
was 3.08 (SD=0.51). Mean score for items on the HFS-W subscale was 2.31 (SD=0.81).
cScale 0-25. Higher score denotes better well-being.
dScale 0-24. Higher score denotes more sleepiness.e 721028
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one of the key contributors to the diabetes burden. Parental well-
being was positively associated with diabetes duration and child
age, whereby child age and diabetes duration were also highly
associated. It may be that caring for a very young child is
generally challenging for parents and especially so when the
child is diagnosed with T1D. As children grow older, parents
may adjust to both parenting and diabetes management, even
when this does not reduce hypoglycemia fear. Further research is
needed to investigate to what extent this relates to general
parenting issues or is affected by the specific challenges
associated with caring for a very young child with T1D.
Twenty-six percent of the parents (6/23) reported child
behavioral difficulties in the high to very high range, signified
by 13% (3/23) scoring very high on subscale emotional
difficulties and 17% (4/23) on conduct problems. These
findings support previous research, indicating that parents
often report higher levels of behavioral difficulties for children
with T1D, most notably a higher incidence of anxiety and
depression and externalizing problems (7, 8, 26).
A negative association was found between parental well-being
and child behavior, but not HbA1c levels. Well-being of parents
is considered relevant for the long-term outcome in children
with diabetes and reduced parental well-being is associated with
an increase in child psychosocial problems and worse glycemic
control (25, 27, 28). Although our results confirm the association
between parental well-being and perceived child behavior, no
association with either construct and HbA1c levels was found.
This may be related to the child´s age, as the glycemic control in
very young children may be mainly determined by the
management behavior of the parent/caregiver and less affected
by child behavior.
Fear of hypoglycemia was not related to HbA1c levels. This
suggests that parental burden is mainly affected by parental
anxiety concerning the management of their child´s diabetes
rather than the actual glycemic control. To this extent, it is
imperative that intervention programs are offered to support
parents in a timely manner and, in effect, improve long-term
outcomes of glycemic control, child behavior and parental well-
being (8, 26).
Some limitations should be considered. Results should be
interpreted with caution given the small sample size. Although
post-hoc power analyses [using G*Power (29)] indicate that theFrontiers in Endocrinology | www.frontiersin.org 4sample size of N=23 provided at least .74 power to detect effect
sizes ≥.44., medium and smaller effects may not have been
detected. Furthermore, our data are all based on parent´s
reflective reporting. In future studies, observational data or
diaries could be used to obtain other indications of parents´
and children´s actual behavior. In addition, the current results
are based on cross-sectional data, allowing for the investigations
of association. Longitudinal studies are however necessary to
investigate causal relationships between the constructs.
Our study also has some specific strength. Using a multicenter
and multinational design, our data can confirm that the burden
of diabetes in the very young children is universal and needs to be
identified and addressed within diabetes care programs to
improve long-term diabetes outcomes and prevent
psychological/behavioral complications. One option may be the
use of hybrid closed-loop systems with age appropriate
algorithms, reducing nocturnal risk of hypoglycemia and
glucose variability. Such intervention has been found to reduce
diabetes burden (15, 30). In addition, family-based interventions,
aimed to support parents in managing their child´s diabetes have
had positive effects on glycemic control as well as parent-child
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